Topical Finasteride in the Treatment of Idiopathic Hirsutism

This study has been completed.
Sponsor:
Collaborator:
Firuzgar hospital affiliated to Iran University of Medical Sciences
Information provided by:
Iran University of Medical Sciences
ClinicalTrials.gov Identifier:
NCT00564252
First received: November 26, 2007
Last updated: NA
Last verified: November 2007
History: No changes posted
  Purpose

the purpose of this study is to evaluate the efficacy of topical Finasteride in the treatment of idiopathic hirsutism


Condition Intervention
Idiopathic Hirsutism
Drug: topical finasteride

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: Single Blind (Subject)
Primary Purpose: Treatment
Official Title: The Efficacy of Topical Finasteride in the Treatment of Idiopathic Hirsutism

Resource links provided by NLM:


Further study details as provided by Iran University of Medical Sciences:

Primary Outcome Measures:
  • the efficacy of topical finasteride was determined by comparison of Ferriman-Gallwey score before and after medication [ Time Frame: 6 months ]

Secondary Outcome Measures:
  • the efficacy of topical finasteride was determined by comparison of mean hair thickness before and after medication [ Time Frame: 6 months ]

Enrollment: 56
Study Start Date: February 2006
Study Completion Date: October 2006
Intervention Details:
    Drug: topical finasteride
    0.2%topical(cream)finasteride twice a day for six months
  Eligibility

Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Idiopathic hirsutism which is defined as normal levels of androgens and normal ovulation
  • Normal serum prolactin

Exclusion Criteria:

  • Pregnancy
  • Simultaneous use of other drugs for the treatment of hirsutism
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00564252

Sponsors and Collaborators
Iran University of Medical Sciences
Firuzgar hospital affiliated to Iran University of Medical Sciences
Investigators
Study Director: iraj heydari, professor assistant endocrine and metabolism centre of Iran University of Medical Sciences
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00564252     History of Changes
Other Study ID Numbers: 84-5-6886, IUMS127
Study First Received: November 26, 2007
Last Updated: November 26, 2007
Health Authority: Iran: Ethics Committee

Additional relevant MeSH terms:
Hirsutism
Hypertrichosis
Hair Diseases
Skin Diseases
Virilism
Signs and Symptoms
Finasteride
5-alpha Reductase Inhibitors
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions

ClinicalTrials.gov processed this record on April 17, 2014